EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leptin/JAK2 Signaling Potentiates BMP9‐Increased Angiogenesis of Mesenchymal Stem Cells

Bo Zhang, Lijuan Yang, Wensheng Liao, Tongchuan He, Elam Coalson, Cody Lee, Guang Yang, Zhenghong Yu, Yanzheng Gao

Stem Cells International · 2026-01 · 2026 (1)

DOI: 10.1155/sci/1844499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells International, online erschienen am 18.11.2026. Verfasst von Bo Zhang und 8 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, Scoliosis Research Society, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overexpression of bone morphogenetic protein 9 (BMP9) in mesenchymal stem cells (MSCs) induces both osteogenic and adipogenic differentiation. Leptin is an adipocyte‐derived hormone and modulates bone mass, mineral density, and energy metabolism. We previously demonstrated that exogenous leptin overexpression potentiated BMP9‐induced osteogenesis and inhibited BMP9‐promoted adipogenesis in MSCs. Nonetheless, it is unclear whether leptin enhances BMP9‐induced angiogenic differentiation of MSCs in bone formation process. Our laboratory established a BMP9 knockout (BMP9‐KO) mouse model and the ectopic bone formation model to investigate the synergistic effect between leptin and BMP9 on angiogenic differentiation of MSCs. In this study, we observed that the BMP9‐KO mice showed similar microarchitectural parameters in limb bones, as assessed by microcomputed tomography (μCT), including similar trabecular thickness (Tb.Th) and bone volume (BV) compared to their wild‐type littermates. Moreover, leptin effectively potentiated BMP9‐induced angiogenic and osteogenic differentiation of MSCs, and the vascular specialization of MSCs occurred concomitantly with trabecular bone matrix deposition. Mechanistically, the leptin‐increased BMP9‐induced angiogenic and osteogenic differentiation were inhibited by a JAK1/2 inhibitor ruxolitinib or JAK2 silencing. Taken together, our results strongly show that leptin may enhance BMP9‐promoted vascularization of MSCs through JAK2 signaling. These outcomes contribute to a new understanding of the combined use of BMP9 and leptin modulated angiogenic differentiation of MSCs, which is beneficial for bone regeneration and fracture healing.

Förderung

  • National Institutes of Health
  • Scoliosis Research Society
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, B., Yang, L., Liao, W., He, T., Coalson, E., Lee, C., Yang, G., Yu, Z., & Gao, Y. (2026). Leptin/JAK2 Signaling Potentiates BMP9‐Increased Angiogenesis of Mesenchymal Stem Cells. Stem Cells International, 2026(1). https://doi.org/10.1155/sci/1844499

Vancouver

Zhang B, Yang L, Liao W, He T, Coalson E, Lee C, et al. Leptin/JAK2 Signaling Potentiates BMP9‐Increased Angiogenesis of Mesenchymal Stem Cells. Stem Cells International. 2026;2026(1). doi:10.1155/sci/1844499

BibTeX
@article{Zhang2026,
  author = {Zhang, Bo and Yang, Lijuan and Liao, Wensheng and He, Tongchuan and Coalson, Elam and Lee, Cody and Yang, Guang and Yu, Zhenghong and Gao, Yanzheng},
  title = {Leptin/JAK2 Signaling Potentiates BMP9‐Increased Angiogenesis of Mesenchymal Stem Cells},
  journal = {Stem Cells International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/sci/1844499}
}
Kostenlos starten →